Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction

Endocrinology

Volumn 152, Issue 5, 2011, Pages 1779-1788

  Chen, Fang ^a   Zhu, Yunxia ^a   Tang, Xinyi ^a   Sun, Yidan ^a   Jia, Weiping ^b   Sun, Yujie ^a   Han, Xiao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Shanghai Clinical Center of Diabetes   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HEPATOCYTE NUCLEAR FACTOR 3BETA; MESSENGER RNA; RNA; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REPORTER GENE; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HOMEODOMAIN PROTEINS; INSULIN-SECRETING CELLS; MALE; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS; TRANS-ACTIVATORS;

EID: 79955421129     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1048     Document Type: Article

References (38)

1. Hoogwerf B, Danese RD 1999 Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin North Am 25:489-505 (Pubitemid 29400386)
2. Schäcke H, Döcke WD, Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43 (Pubitemid 35346616)
3. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA 1997 Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 321 (Pt 3):707-712 (Pubitemid 27084879)
4. Tounian P, Schneiter P, Henry S, Delarue J, Tappy L 1997 Effects of dexamethasone on hepatic glucose production and fructose metabolism in healthy humans. Am J Physiol 273: E315-E320
5. Burén J, Liu HX, Jensen J, Eriksson JW 2002 Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol 146:419-429 (Pubitemid 34257654)
6. Ruzzin J, Wagman AS, Jensen J 2005 Glucocorticoid-inducedinsulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48:2119-2130 (Pubitemid 41416925)
7. Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S 1997 Pancreatic β cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 100:2094-2098 (Pubitemid 27459365)
8. Breant B, Gesina E, Blondeau B 2006 Nutrition, glucocorticoids and pancreas development. Horm Res 65 (Suppl 3):98-104 (Pubitemid 44689440)
9. Shinozuka Y, Okada M, Oki T, Sagane K, Mizui Y, Tanaka I, Katayama K, Murakami-Murofushi K 2001 Altered expression of HES-1, β2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells. Biochem Biophys Res Commun 287:229-235 (Pubitemid 32916119)
10. Melloul D 2004 Transcription factors in islet development and physiology: role of PDX-1 in β-cell function. Ann NY Acad Sci 1014:28-37 (Pubitemid 38594788)
11. Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ 2005 β-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54:482-491
12. Marshak S, Ben-Shushan E, Shoshkes M, Havin L, Cerasi E, Melloul D 2001 Regulatory elements involved in human pdx-1 gene expression. Diabetes 50 (Suppl 1): S37-S38 (Pubitemid 32148214)
13. Melloul D, Marshak S, Cerasi E 2002 Regulation of pdx-1 gene expression. Diabetes 51 Suppl 3: S320-325 (Pubitemid 35403411)
14. Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R 1997 Hepatocyte nuclear factor 3β is involved in pancreatic β-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17:6002-6013 (Pubitemid 27411108)
15. Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D 2001 A pancreatic β-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3β (HNF-3β), HNF-1α, and SPs transcription factors. J Biol Chem 276:17533-17540
16. Nakae J, Biggs 3rd WH, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D 2002 Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245-253
17. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-1847 (Pubitemid 36076491)
18. Sharma S, Jhala US, Johnson T, Ferreri K, Leonard J, Montminy M 1997 Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol Cell Biol 17:2598-2604 (Pubitemid 27175141)
19. Zhang X, Yong W, Lv J, Zhu Y, Zhang J, Chen F, Zhang R, Yang T, Sun Y, Han X 2009 Inhibition of forkhead box O1 protects pancreatic β-cells against dexamethasone-induced dysfunction. Endocrinology 150:4065-4073
20. Han X, Sun Y, Scott S, Bleich D 2001 Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and β-cells. Diabetes 50:1047-1055 (Pubitemid 32374535)
21. Meng ZX, Nie J, Ling JJ, Sun JX, Zhu YX, Gao L, Lv JH, Zhu DY, Sun YJ, Han X 2009 Activation of liver X receptors inhibits pancreatic islet β cell proliferation through cell cycle arrest. Diabetologia 52:125-135
22. Meng Z, Lv J, Luo Y, Lin Y, Zhu Y, Nie J, Yang T, Sun Y, Han X 2009 Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun. N-terminal kinase and involved in prostaglandin E2-induced pancreatic β-cell dysfunction. Endocrinology 150:5284-5293
23. Zhang HJ, Walseth TF, Robertson RP 1989 Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes 38:44-48 (Pubitemid 19021815)
24. Chakrabarti SK, James JC, Mirmira RG 2002 Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem 277:13286-13293 (Pubitemid 34952700)
25. Lee CS, Sund NJ, Vatamaniuk MZ, Matschinsky FM, Stoffers DA, Kaestner KH 2002 Foxa2 controls Pdx1 gene expression in pancreatic β-cells in vivo. Diabetes 51:2546-2551 (Pubitemid 34827405)
26. Lee CS, Friedman JR, Fulmer JT, Kaestner KH 2005 The initiation of liver development is dependent on Foxa transcription factors. Nature 435:944-947 (Pubitemid 40896319)
27. Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang SL, Wert S, Stahlman MT, Whitsett JA 2005 Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem 280:13809-13816 (Pubitemid 40517278)
28. Kaestner KH 2010 The FoxA factors in organogenesis and differentiation. Curr Opin Genet Dev 20:527-532
29. Kaestner KH 2000 The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab 11:281-285
30. Kaestner KH, Hiemisch H, Schütz G 1998 Targeted disruption of the gene encoding hepatocyte nuclear factor 3γ results in reduced transcription of hepatocyte-specific genes. Mol Cell Biol 18:4245-4251 (Pubitemid 28287947)
31. Lantz KA, Vatamaniuk MZ, Brestelli JE, Friedman JR, Matschinsky FM, Kaestner KH 2004 Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest 114:512-520 (Pubitemid 39572101)
32. Gao N, White P, Doliba N, Golson ML, Matschinsky FM, Kaestner KH 2007 Foxa2 controls vesicle docking and insulin secretion in mature β cells. Cell Metab 6:267-279 (Pubitemid 47450186)
33. Gao N, Le Lay J, Vatamaniuk MZ, Rieck S, Friedman JR, Kaestner KH 2008 Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev 22:3435-3448
34. Edlund H 2001 Developmental biology of the pancreas. Diabetes 50 (Suppl 1): S5-S9
35. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC 2002 Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232 (Pubitemid 34952885)
36. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, White MF 2002 Pdx1 restores β cell function in Irs2 knockout mice. J Clin Invest 109:1193-1201 (Pubitemid 34496597)
37. Wang H, Gauthier BR, Hagenfeldt-Johansson KA, Iezzi M, Wollheim CB 2002 Foxa2 (HNF3β) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J Biol Chem 277:17564-17570 (Pubitemid 34967558)
38. Meng ZX, Sun JX, Ling JJ, Lv JH, Zhu DY, Chen Q, Sun YJ, Han X 2006 Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet β cell dysfunction. Diabetologia 49:2959-2968 (Pubitemid 44730299)